187 related articles for article (PubMed ID: 15857401)
21. Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine.
Cichewicz DL; Haller VL; Welch SP
J Pharmacol Exp Ther; 2001 Apr; 297(1):121-7. PubMed ID: 11259535
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
23. Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims.
Vinod KY; Arango V; Xie S; Kassir SA; Mann JJ; Cooper TB; Hungund BL
Biol Psychiatry; 2005 Mar; 57(5):480-6. PubMed ID: 15737662
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
25. Chronic Delta9-tetrahydrocannabinol treatment produces antinociceptive tolerance in mice without altering protein kinase A activity in mouse brain and spinal cord.
Dalton GD; Smith FL; Smith PA; Dewey WL
Biochem Pharmacol; 2005 Jul; 70(1):152-60. PubMed ID: 15913565
[TBL] [Abstract][Full Text] [Related]
26. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
Jardinaud F; Roques BP; Noble F
Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
[TBL] [Abstract][Full Text] [Related]
27. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
28. Extracellular signal-regulated kinases (ERKs) modulate cocaine-induced gene expression in the mouse amygdala.
Radwanska K; Caboche J; Kaczmarek L
Eur J Neurosci; 2005 Aug; 22(4):939-48. PubMed ID: 16115217
[TBL] [Abstract][Full Text] [Related]
29. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
30. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.
Kim SE; Choi KY
Cell Signal; 2007 Jul; 19(7):1554-64. PubMed ID: 17374561
[TBL] [Abstract][Full Text] [Related]
31. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
[TBL] [Abstract][Full Text] [Related]
32. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.
Lu T; Newton C; Perkins I; Friedman H; Klein TW
Eur J Pharmacol; 2006 Feb; 532(1-2):170-7. PubMed ID: 16443217
[TBL] [Abstract][Full Text] [Related]
33. APC inhibits ERK pathway activation and cellular proliferation induced by RAS.
Park KS; Jeon SH; Kim SE; Bahk YY; Holmen SL; Williams BO; Chung KC; Surh YJ; Choi KY
J Cell Sci; 2006 Mar; 119(Pt 5):819-27. PubMed ID: 16478791
[TBL] [Abstract][Full Text] [Related]
34. Regulation of cocaine-induced activator protein 1 transcription factors by the extracellular signal-regulated kinase pathway.
Radwanska K; Valjent E; Trzaskos J; Caboche J; Kaczmarek L
Neuroscience; 2006; 137(1):253-64. PubMed ID: 16263220
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
36. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
[TBL] [Abstract][Full Text] [Related]
37. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
De Vry J; Jentzsch KR
Behav Pharmacol; 2003 Sep; 14(5-6):471-6. PubMed ID: 14501260
[TBL] [Abstract][Full Text] [Related]
38. Extracellular signal-regulated kinase activation is required for consolidation and reconsolidation of memory at an early stage of ontogenesis.
Languille S; Davis S; Richer P; Alcacer C; Laroche S; Hars B
Eur J Neurosci; 2009 Nov; 30(10):1923-30. PubMed ID: 19895565
[TBL] [Abstract][Full Text] [Related]
39. Activation of the extracellular signal-regulated kinase pathway contributes to the behavioral deficit of fragile x-syndrome.
Wang X; Snape M; Klann E; Stone JG; Singh A; Petersen RB; Castellani RJ; Casadesus G; Smith MA; Zhu X
J Neurochem; 2012 May; 121(4):672-9. PubMed ID: 22393900
[TBL] [Abstract][Full Text] [Related]
40. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
